Bladex Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $303.6M+14.1% YoYTTM through 31 Dec 2024
Net Income $205.9M+23.9% YoYTTM through 31 Dec 2024
Free Cash Flow -$124.5MTTM through 31 Dec 2024
Margins
| Current | |
|---|---|
| Operating Margin | 66.8% |
| Net Margin | 67.8% |
Returns
15.4%ROE
1.8%ROA
5.4%ROIC
Balance Sheet Health
Debt / Equity6.62x
Net Debt$9.2B
Cash & Equivalents$1.9B
Quality Metrics
FCF Margin-41.0%
Rule of 40-16.5
Multi-Year Trend
RevenueFY2024: $303.6M
Diluted EPS$5.60TTMFY2024: $5.60
Dividend
$1.38Per share, FY20264.47%Yield1 yrsStreak+6.6%5-yr growth
Capital Allocation
Capex Intensity0.6%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Commercial | |||
| Treasury |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.